UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 370

Sortiert nach

Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules

Antiviral research, 2015-06, Vol.118, p.75-81

2015

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice

Antiviral research, 2005-10, Vol.68 (1), p.43-48

2005

Link zum Volltext

Verfügbarkeit prüfen

Cold oxygen plasma technology efficiency against different airborne respiratory viruses

Journal of clinical virology, 2009-06, Vol.45 (2), p.119-124

2009

Link zum Volltext

Verfügbarkeit prüfen

In vitro characterization of naturally occurring influenza H3NA− viruses lacking the NA gene segment: Toward a new mechanism of viral resistance?

Virology (New York, N.Y.), 2010-09, Vol.404 (2), p.215-224

2010

Link zum Volltext

Verfügbarkeit prüfen

Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants

Journal of clinical virology, 2008-09, Vol.43 (1), p.86-92

2008

Link zum Volltext

Verfügbarkeit prüfen

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance

Journal of clinical virology, 2008-01, Vol.41 (1), p.13-19

2008

Link zum Volltext

Verfügbarkeit prüfen

Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic

Epidemiology and infection, 2010-09, Vol.138 (9), p.1274-1280

2010

Link zum Volltext

Verfügbarkeit prüfen

Manifiesto del nuevo realismo

Ferraris, Maurizio

2012

Link zum Volltext

Verfügbarkeit prüfen

P.066 Consequences of combinations of mutations in the neuraminidase active site on the cell surface expression, the activity and the sensibility of the neuraminidase to the neuraminidase inhibitors

Journal of clinical virology, 2009, Vol.44, p.S31-S31

2009

Link zum Volltext

Verfügbarkeit prüfen

Anti N1 Cross-Protecting Antibodies Against H5N1 Detected in H1N1 Infected People

Current microbiology, 2010-07, Vol.61 (1), p.25-28

2010

Link zum Volltext

Verfügbarkeit prüfen

Crimean-Congo hemorrhagic fever virus replication imposes hyper-lipidation of MAP1LC3 in epithelial cells

Autophagy, 2020-10, Vol.16 (10), p.1858-1870

2020

Link zum Volltext

Verfügbarkeit prüfen

O.7.4 Detection of neuraminidase cross-protection antibodies against H5N1 in H1N1 infected or vaccinated humans

Journal of clinical virology, 2009, Vol.44, p.S15-S15

2009

Link zum Volltext

Verfügbarkeit prüfen

P.060 Influenza A viruses host ultrastructural nuclear modifications: specific different patterns between avian and human strains?

Journal of clinical virology, 2009, Vol.44, p.S30-S30

2009

Link zum Volltext

Verfügbarkeit prüfen

Human parainfluenza virus type 4 infections: A report of 20 cases from 1998 to 2002

Journal of clinical virology, 2005-09, Vol.34 (1), p.48-51

2005

Link zum Volltext

Verfügbarkeit prüfen

Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001–2002

Journal of clinical virology, 2005-07, Vol.33 (3), p.230-236

2005

Link zum Volltext

Verfügbarkeit prüfen

Use of the DNA Flow-Thru Chip, a Three-Dimensional Biochip, for Typing and Subtyping of Influenza Viruses

Journal of Clinical Microbiology, 2004-05, Vol.42 (5), p.2173-2185

2004

Link zum Volltext

Verfügbarkeit prüfen

Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors

Journal of clinical virology, 2008-01, Vol.41 (1), p.25-28

2008

Link zum Volltext

Verfügbarkeit prüfen

An atypical necrotic wound

Médecine et maladies infectieuses, 2015-03, Vol.45 (3), p.98-100

2015

Link zum Volltext

Verfügbarkeit prüfen

ORIGINAL IN-SILICO APPROACH IDENTIFIES NEW BROAD-SPECTRUM INFLUENZA A ANTIVIRALS

Intensive care medicine, 2010, Vol.36

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors

Journal of clinical virology, 2008-01, Vol.41 (1), p.20-24

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of a late AH1N2 human reassortant in France during the 2002–2003 influenza season

Virus research, 2008-03, Vol.132 (1), p.33-41

2008

Link zum Volltext

Verfügbarkeit prüfen

Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance

Antiviral therapy, 2010-01, Vol.15 (5), p.721-726

2010

Link zum Volltext

Verfügbarkeit prüfen

Consequences of combinations of mutations in the neuraminidase active site on the cell surface expression, the activity and the sensibility of the neuraminidase to the neuraminidase inhibitors

Journal of clinical virology, 2009-01, Vol.44, p.S31-S31

2009

Link zum Volltext

Verfügbarkeit prüfen

Detection of neuraminidase cross-protection antibodies against H5N1 in H1N1 infected or vaccinated humans

Journal of clinical virology, 2009-01, Vol.44, p.S15-S15

2009

Link zum Volltext

Verfügbarkeit prüfen

Influenza A viruses host ultrastructural nuclear modifications: specific different patterns between avian and human strains?

Journal of clinical virology, 2009-01, Vol.44, p.S30-S30

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 370

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(291)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules

Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice

Cold oxygen plasma technology efficiency against different airborne respiratory viruses

In vitro characterization of naturally occurring influenza H3NA− viruses lacking the NA gene segment: Toward a new mechanism of viral resistance?

Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance

Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic

Manifiesto del nuevo realismo

P.066 Consequences of combinations of mutations in the neuraminidase active site on the cell surface expression, the activity and the sensibility of the neuraminidase to the neuraminidase inhibitors

Anti N1 Cross-Protecting Antibodies Against H5N1 Detected in H1N1 Infected People

Crimean-Congo hemorrhagic fever virus replication imposes hyper-lipidation of MAP1LC3 in epithelial cells

O.7.4 Detection of neuraminidase cross-protection antibodies against H5N1 in H1N1 infected or vaccinated humans

P.060 Influenza A viruses host ultrastructural nuclear modifications: specific different patterns between avian and human strains?

Human parainfluenza virus type 4 infections: A report of 20 cases from 1998 to 2002

Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001–2002

Use of the DNA Flow-Thru Chip, a Three-Dimensional Biochip, for Typing and Subtyping of Influenza Viruses

Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors

An atypical necrotic wound

ORIGINAL IN-SILICO APPROACH IDENTIFIES NEW BROAD-SPECTRUM INFLUENZA A ANTIVIRALS

Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors

Identification and characterization of a late AH1N2 human reassortant in France during the 2002–2003 influenza season

Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance

Consequences of combinations of mutations in the neuraminidase active site on the cell surface expression, the activity and the sensibility of the neuraminidase to the neuraminidase inhibitors

Detection of neuraminidase cross-protection antibodies against H5N1 in H1N1 infected or vaccinated humans

Influenza A viruses host ultrastructural nuclear modifications: specific different patterns between avian and human strains?

Aktive Filter

Suchergebnisse filtern